- Drug Pipelines
- November 2020
- 93 Pages
Global
From €1805EUR$2,000USD£1,564GBP
- Drug Pipelines
- November 2020
- 65 Pages
Global
From €1805EUR$2,000USD£1,564GBP
- Drug Pipelines
- November 2020
- 114 Pages
Global
From €1805EUR$2,000USD£1,564GBP
- Drug Pipelines
- September 2020
- 68 Pages
Global
From €1805EUR$2,000USD£1,564GBP
- Drug Pipelines
- September 2020
- 96 Pages
Global
From €1805EUR$2,000USD£1,564GBP
- Drug Pipelines
- September 2020
- 737 Pages
Global
From €2256EUR$2,500USD£1,955GBP
- Drug Pipelines
- August 2020
- 384 Pages
Global
From €1805EUR$2,000USD£1,564GBP
- Drug Pipelines
- August 2020
- 123 Pages
Global
From €1805EUR$2,000USD£1,564GBP
- Drug Pipelines
- August 2020
- 345 Pages
Global
From €1805EUR$2,000USD£1,564GBP
- Drug Pipelines
- July 2020
- 75 Pages
Global
From €1805EUR$2,000USD£1,564GBP
- Drug Pipelines
- July 2020
- 96 Pages
Global
From €1805EUR$2,000USD£1,564GBP
- Drug Pipelines
- July 2020
- 152 Pages
Global
From €1805EUR$2,000USD£1,564GBP
- Drug Pipelines
- July 2020
- 197 Pages
Global
From €1805EUR$2,000USD£1,564GBP
- Drug Pipelines
- July 2020
- 61 Pages
Global
From €3159EUR$3,500USD£2,737GBP
- Drug Pipelines
- July 2020
- 1191 Pages
Global
From €2256EUR$2,500USD£1,955GBP
- Drug Pipelines
- July 2020
- 222 Pages
Global
From €1805EUR$2,000USD£1,564GBP
- Report
- March 2025
- 159 Pages
From €3114EUR$3,450USD£2,698GBP
- Report
- March 2025
- 204 Pages
North America
From €3114EUR$3,450USD£2,698GBP
- Report
- March 2025
- 172 Pages
Middle East, Africa
From €3114EUR$3,450USD£2,698GBP
- Report
- March 2025
- 209 Pages
Europe
From €3114EUR$3,450USD£2,698GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more